SecBot SecBot
S-1/A ·Filed Jul 31, 2026

GRDX

GridAI Technologies Corp.
BEARISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001104659-26-089198
IPO registration amendment
Actionable Insight ▼ Bearish

The S-1 effectiveness is the critical near-term catalyst. If declared effective, the company receives ~$12.3M in additional proceeds, extending its runway to ~18 months. If not effective by January 2027, the company faces a high risk of ceasing operations. Monitor for SEC comments and the effectiveness date. The massive potential dilution from Series H Preferred Stock conversion (~84.9%) is a significant overhang.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
GRDX ▲ +27.84% at T+20d
SHORT call ✗ call lost -27.84% · α vs SPY -26.60% · entry $2.91 → $3.72
Next anchor: T+60d due 20h ago
Latest observation: T+58 -44.35% FF3 residual α
Entry = T+0 close
Jul 31, 2026
via day close
T+1d
-5.50%
call +5.50% · α +7.30%
$2.75
settled 3mo ago
T+5d
+3.44%
call -3.44% · α -1.41%
$3.01
settled 3mo ago
T+20d
+27.84%
call -27.84% · α -26.60%
$3.72
settled 2mo ago
T+60d
Pending
due 20h ago

Executive Summary

GridAI Technologies Corp. filed Amendment No. 2 to its S-1 registration statement to register the resale of 9,908,766 shares of common stock held by selling stockholders, including shares issuable upon exercise of pre-funded and common warrants from May and July 2026 private placements. The company is in a precarious financial position with only ~$386,000 cash at March 31, 2026, a $212.1 million accumulated deficit, an auditors' going-concern opinion, and a material weakness in internal controls. While the recent financings provide a path to fund operations for about 18 months if the registration statement is declared effective, failure to do so by January 2027 could force the company to curtail or cease operations.

Key Facts

  • GridAI is a diversified technology and life sciences company operating through energy orchestration software (Grid AI Corp.) and legacy biopharmaceutical development (Adrulipase).
  • As of March 31, 2026, the company had only ~$386,000 in cash and cash equivalents and an accumulated deficit of ~$212.1 million.
  • The company received ~$4 million in gross proceeds from May and July 2026 private placements, with an additional ~$12.3 million due before the S-1 is declared effective.
  • The company's independent auditors have expressed substantial doubt about its ability to continue as a going concern.
  • The company has a material weakness in internal control over financial reporting.
  • The company's current burn rate is ~$7.8 million per year, and it expects to have sufficient liquidity for ~18 months if the S-1 is declared effective.
  • If the S-1 is not effective by January 2027, the company may be forced to curtail or cease operations.
  • The company faces a pending arbitration from WestPark Capital seeking ~$2.06 million in damages.
  • The company is considering amending milestones to allow conversion of Series H Preferred Stock, which could result in ~84.9% dilution for existing stockholders.

Financial Impact

Company has ~$386,000 cash, $212.1M accumulated deficit, $7.8M annual burn rate, and is dependent on ~$12.3M in additional proceeds from private placements tied to S-1 effectiveness.

cashaccumulated deficitworking capitaldilution

Risk Factors

  • Going-concern risk: auditors have expressed substantial doubt about ability to continue as a going concern.
  • Dilution risk: Series H Preferred Stock conversion could reduce existing stockholders' ownership by ~84.9%.
  • Financing risk: failure to declare S-1 effective by January 2027 could force cessation of operations.
  • Litigation risk: pending arbitration from WestPark Capital seeking ~$2.06 million.
  • Operational risk: no revenue from AI platform yet; consulting revenue expected in ~4 months and SaaS revenue in 6-9 months.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001104659-26-089198
Document: tm2615795d6_ex10-35.htm0001104659-26-089198
Document: tm2615795d6_ex10-32.htm0001104659-26-089198
10 reports for GRDX
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 3 of 5 best @ T+20▲ +39.11%Jul 9, 2026
Filters
Rows
Reports for GRDX — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
NEUTRAL ★ 2/10
$5.40awaiting T+1—$5.55 (+2.78%)
Oct 20, 2026
7d ago
EFFECT
MIXED ★ 6/10
$4.63 $4.90▲ +5.83%▲ +5.31%$5.55 (+19.87%)
Oct 7, 2026
19d ago
8-K
NEUTRAL ★ 3/10
$4.80 $4.97▲ +3.54%▲ +2.94%$5.55 (+15.63%)
Oct 6, 2026
20d ago
S-1/A
BEARISH ★ 7/10
$4.12 $4.80▼ −16.50%▼ −16.93%$5.55 (−34.71%)
Aug 24, 2026
9w ago
S-1/A
BEARISH ★ 7/10
$3.65 $4.06▼ −11.23%▼ −10.91%$5.55 (−52.05%)
Jul 31, 2026
12w ago
S-1/A
BEARISH ★ 6/10
$2.91 $2.75▲ +5.50%▲ +7.30%$5.55 (−90.72%)
Jul 23, 2026
13w ago
8-K
NEUTRAL ★ 5/10
$3.04 $3.15▲ +3.62%▲ +3.60%$5.55 (+82.57%)
Jul 9, 2026
15w ago
S-1/A
BEARISH ★ 5/10
$4.50 $4.07▲ +9.56%▲ +8.79%$5.55 (−23.33%)
May 14, 2026
23w ago
8-K
BEARISH ★ 7/10
$3.87 $3.78▲ +2.33%▲ +2.26%$5.55 (−43.41%)
Apr 24, 2026
26w ago
8-K
BEARISH ★ 7/10
$2.25 $2.24▲ +0.44%▼ −0.04%$5.55 (−146.67%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 5h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 31, 2026